Blood level of cyclosporin [correction of cyclospolin] during LDL-apheresis in nephrotic syndrome patients.
Nakajima
F
F
Department of Urology, Osaka Medical College, Osaka, Japan.
Shibahara
N
N
Ijiri
Y
Y
Ashida
A
A
Ueda
H
H
Katsuoka
Y
Y
D000293:Adolescent; D000327:Adsorption; D001781:Blood Component Removal; D002648:Child; D016572:Cyclosporine / Q000097:blood* / Q000737:chemistry / Q000493:pharmacokinetics; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000493:pharmacokinetics; D008077:Lipoproteins, LDL / Q000737:chemistry*; D009404:Nephrotic Syndrome / Q000097:blood* / Q000188:drug therapy / Q000209:etiology / Q000628:therapy
D007166:Immunosuppressive Agents; D008077:Lipoproteins, LDL; D016572:Cyclosporine